70
Overbought
Moving averages
SMA 200$142.69+53.76%
Company profile
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$28.96B
P/E ratio35.06
EPS$5.47
Beta1.464
Dividend yield0.00%
52-week high$207.00
52-week low$88.00
Similar stocks in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
RSI 75
MTD
Mettler-Toledo International Inc
RSI 54
CSTL
Castle Biosciences Inc
RSI 71
FONR
Fonar Corp
RSI 75
CRL
Charles River Laboratories International Inc
RSI 76
BDSX
Biodesix Inc
RSI 64
NTRA
Natera Inc
RSI 72
WGS
GeneDx Holdings Corp - Class A
RSI 71
DGX
Quest Diagnostics Inc
RSI 36
NEO
Neogenomics Inc
RSI 35
RSI alerts for ILMN
Get an email the moment Illumina Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 3:53 AM EDT